retatrutide case study Tirzepatide vs. Retatrutide: Key Differences Explained Retatrutide (LY-3437943) Market Analysis, 2033:

These findings indicate that although the observed protective effects are not limited to hepatocytes, they require defined cell-specific components for NFT activation

FTC guidance separately requires health-related claims and testimonials to be truthful, not misleading, and properly substantiated

Both oral and injectable formulations offer benefits but they differ in delivery, bioavailability, and patient suitability

3.5 Safety evaluation The AEs occurred in the RG and RG + CHF group were demonstrated below (Table 6)

It's something doctors and researchers have started noticing, but as yet we don't have much in the way of solid evidence about a connection

Camilleri M, Lupianez-Merly C (2024) Effects of GLP-1 and other gut hormone receptors on the gastrointestinal tract and implications in clinical practice